Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphatidylcholine transporter activity	ABCA3 PITPNM2 PITPNM1 MTTP	3.70e-05	20	194	4	GO:0008525
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	TRPM4 ATP7B PKD1L1 SLC30A2 RYR2 SCNN1D TRPV6 SLC17A4 SLC1A7 SLC5A2 SLC9A1 GHITM SLC28A1 ATP1A2 TRPV5	5.20e-05	465	194	15	GO:0046873
GeneOntologyMolecularFunction	endoribonuclease activity, cleaving miRNA-paired mRNA	AGO2 AGO3	9.39e-05	2	194	2	GO:0090624
GeneOntologyMolecularFunction	phospholipid transfer activity	ABCA3 PITPNM2 PITPNM1 MTTP	1.09e-04	26	194	4	GO:0120014
GeneOntologyMolecularFunction	transporter activity	TRPM4 ABCA3 ATP7B PLSCR5 GJB4 PKD1L1 SLC30A2 RYR2 CLCN6 CLCN7 SCNN1D TRPV6 LRRC8E PITPNM2 SLC26A3 SLC17A4 SLC7A14 SLC1A7 SLC5A2 PITPNM1 SLC9A1 SLC25A2 GHITM SLC28A1 MTTP ATP1A2 TRPV5	1.33e-04	1289	194	27	GO:0005215
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC30A2 CLCN6 CLCN7 SLC26A3 SLC17A4 SLC1A7 SLC5A2 SLC9A1 SLC25A2 GHITM SLC28A1	1.58e-04	296	194	11	GO:0015291
GeneOntologyMolecularFunction	active transmembrane transporter activity	ABCA3 ATP7B SLC30A2 CLCN6 CLCN7 SLC26A3 SLC17A4 SLC1A7 SLC5A2 SLC9A1 SLC25A2 GHITM SLC28A1 ATP1A2	2.47e-04	477	194	14	GO:0022804
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	TRPM4 SCNN1D SLC17A4 SLC1A7 SLC5A2 SLC9A1 SLC28A1 ATP1A2	2.74e-04	171	194	8	GO:0015081
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	TRPM4 ATP7B PKD1L1 SLC30A2 RYR2 CLCN6 CLCN7 SCNN1D TRPV6 LRRC8E SLC26A3 SLC17A4 SLC1A7 SLC5A2 SLC9A1 GHITM SLC28A1 ATP1A2 TRPV5	2.76e-04	793	194	19	GO:0015075
GeneOntologyMolecularFunction	antiporter activity	SLC30A2 CLCN6 CLCN7 SLC26A3 SLC9A1 SLC25A2 GHITM	4.07e-04	138	194	7	GO:0015297
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	TRPM4 ATP7B PKD1L1 SLC30A2 RYR2 CLCN6 CLCN7 SCNN1D TRPV6 SLC26A3 SLC17A4 SLC1A7 SLC5A2 SLC9A1 GHITM SLC28A1 ATP1A2 TRPV5	4.45e-04	758	194	18	GO:0015318
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	ATP7B SLC30A2 SLC26A3 SLC17A4 SLC1A7 SLC5A2 SLC9A1 GHITM SLC28A1 ATP1A2	7.50e-04	301	194	10	GO:0022853
GeneOntologyMolecularFunction	phospholipid transporter activity	ABCA3 PLSCR5 PITPNM2 PITPNM1 MTTP	7.70e-04	74	194	5	GO:0005548
GeneOntologyBiologicalProcess	response to mechanical stimulus	PKD1L1 PTGS2 RYR2 CLCN6 COL6A1 FOS NTRK1 DDR2 SLC9A1 ATP1A2 HTT	2.45e-05	247	195	11	GO:0009612
GeneOntologyBiologicalProcess	mitochondrial transport	HK2 PSEN2 SLC30A2 PNPT1 HSPA9 COL6A1 SLC9A1 SLC25A2 GHITM HTT	2.66e-05	205	195	10	GO:0006839
GeneOntologyBiologicalProcess	mitochondrial transmembrane transport	PSEN2 SLC30A2 PNPT1 HSPA9 COL6A1 SLC25A2 GHITM	6.71e-05	106	195	7	GO:1990542
GeneOntologyBiologicalProcess	import across plasma membrane	TRPM4 SCNN1D TRPV6 LRRC8E SLC5A2 ARG1 SLC9A1 SLC28A1 ATP1A2 TRPV5	7.03e-05	230	195	10	GO:0098739
GeneOntologyBiologicalProcess	proteinogenic amino acid catabolic process	MCCC1 IVD GLUL TAT SCLY ARG1	7.74e-05	75	195	6	GO:0170040
GeneOntologyBiologicalProcess	calcium ion transmembrane transport	TRPM4 PSEN2 PKD1L1 DYSF RYR2 TRPV6 HSPA9 FBXO11 SLC9A1 GHITM ATP1A2 TRPV5 HTT	9.64e-05	392	195	13	GO:0070588
GeneOntologyBiologicalProcess	L-amino acid catabolic process	MCCC1 IVD GLUL TAT SCLY ARG1	1.11e-04	80	195	6	GO:0170035
GeneOntologyBiologicalProcess	sodium ion import across plasma membrane	TRPM4 SCNN1D SLC5A2 SLC9A1	1.15e-04	27	195	4	GO:0098719
GeneOntologyBiologicalProcess	response to muscle stretch	RYR2 FOS DDR2 SLC9A1	1.33e-04	28	195	4	GO:0035994
GeneOntologyBiologicalProcess	regulation of cardiac muscle contraction by calcium ion signaling	HDAC4 RYR2 SLC9A1 ATP1A2	1.33e-04	28	195	4	GO:0010882
GeneOntologyCellularComponent	brush border	MYO1A MYO1C CGN LIMA1 SLC26A3 SLC17A4 SLC5A2 SLC28A1 MTTP	1.32e-05	152	195	9	GO:0005903
GeneOntologyCellularComponent	brush border membrane	LIMA1 SLC26A3 SLC17A4 SLC5A2 SLC28A1 MTTP	1.27e-04	83	195	6	GO:0031526
GeneOntologyCellularComponent	cluster of actin-based cell projections	MYO1A MYO1C CGN LIMA1 SLC26A3 SLC17A4 SLC5A2 SLC28A1 MTTP	2.56e-04	223	195	9	GO:0098862
GeneOntologyCellularComponent	sarcolemma	DYSF RTN2 RYR2 COL6A1 SLC9A1 ATP1A2 FLOT1 AHNAK2	4.25e-04	190	195	8	GO:0042383
GeneOntologyCellularComponent	late endosome	ABCA3 ATP7B VPS13C DYSF SLC30A2 CLCN6 NTRK1 CHMP2B IGF2R DYNC1LI1 HTT	4.46e-04	348	195	11	GO:0005770
Pathway	REACTOME_STIMULI_SENSING_CHANNELS	TRPM4 RYR2 CLCN6 CLCN7 SCNN1D TRPV6 TRPV5	1.05e-04	106	144	7	M27200
Pathway	REACTOME_ION_CHANNEL_TRANSPORT	TRPM4 ATP7B RYR2 CLCN6 CLCN7 SCNN1D TRPV6 ATP1A2 TRPV5	1.09e-04	183	144	9	M997
Pathway	REACTOME_UREA_CYCLE	NMRAL1 ARG1 SLC25A2	1.19e-04	10	144	3	M27677
Pathway	REACTOME_UREA_CYCLE	NMRAL1 ARG1 SLC25A2	1.19e-04	10	144	3	MM15396
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRPM4 MYCBP2 CDK12 ITGA3 DYSF RNF43 FAT1 MDN1 CLCN7 CANT1 NCAPD2 NLRC5 TOP3B LRRC8E PITPNM2 HSPG2 NRF1 UBR4 LAD1 KTI12 SMG5 KANSL3 GAS2L1 SH3PXD2B IGF2R ZNF335 PAXIP1 PDCD11 HTT AHNAK2	1.84e-12	1105	200	30	35748872
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GPRASP1 HK2 MYCBP2 MCCC1 RYR2 YTHDF1 GSPT2 PLAA GLUL VARS1 HSPA9 PITPNM2 HSPE1 UBR4 BRSK2 LRRC4C IDH3A PITPNM1 KIAA1217 CNDP2 DYNC1LI1 MACF1 ATP1A2 FLOT1 PPP6R2 PCCB SNX1	5.27e-10	1139	200	27	36417873
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	TRPM4 ATP7B PSEN2 ITGA3 FAT1 PTPRA MDN1 AGO3 CLCN7 CANT1 ALG8 HSPA9 HSPE1 CCNT1 SLC9A1 IGF2R SLC25A2 CNDP2 DYNC1LI1 MACF1 PCCB SNX1 CUX1	5.68e-08	1061	200	23	33845483
Pubmed	Human transcription factor protein interaction networks.	ZHX3 AGO2 ERG MYO1C PABPC4 GON4L ACTL6A MCCC1 EYA3 YTHDF1 FAT1 AGO3 NIP7 HSPE1 HSPG2 LIMA1 FOS UBR4 SMG5 ASH2L KANSL3 PAXIP1 PDCD11 FLOT1 PCCB CUX1 YTHDF3	6.13e-08	1429	200	27	35140242
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	ERG MYO1C MCCC1 GSPT2 CGN HSPA9 LIMA1 LAD1 KIAA1217 CNDP2 DYNC1LI1 MACF1 AHNAK2	1.96e-07	360	200	13	33111431
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	AGO2 MYO1C PABPC4 PTGS2 PTPRA CLCN6 GLUL ALDOC VARS1 HSPA9 PITPNM2 LIMA1 NCKIPSD BRSK2 IDH3A VIRMA PITPNM1 GAS2L1 KIAA1217 NCAN AP3B2 MAST1 MACF1 ATP1A2 FLOT1 PPP6R2	2.34e-07	1431	200	26	37142655
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	AGO2 MYCBP2 PABPC4 SPART MCCC1 DYSF YTHDF1 AGO3 LPCAT2 TOP3B VARS1 SMG5 CHMP2B SH3PXD2B MACF1 PCCB YTHDF3 AHNAK2	2.40e-07	724	200	18	36232890
Pubmed	Large-scale analysis of the human ubiquitin-related proteome.	AGO2 MYCBP2 PABPC4 SPART ACTL6A AGO3 GLUL ALDOC UBR4 PNMA8A KLHL12 FLOT1	3.10e-07	313	200	12	16196087
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TES AGO2 MYCBP2 CDK12 ACTL6A GTF3C5 CGN NCAPD2 LIMA1 ASH2L SH3PXD2B PDCD11 SNX1 CUX1 HTT	7.85e-07	549	200	15	38280479
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 GPRASP1 AGO2 HDAC4 MYCBP2 MDN1 AGO3 GLUL TOP3B HSPA9 LIMA1 UBR4 VIRMA SH3PXD2B IGF2R KIAA1217 NCAN MACF1 PPP6R2 CUX1	8.54e-07	963	200	20	28671696
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MAGI1 AGO2 HDAC4 MYO1C PABPC4 ACTL6A PNPT1 GSPT2 CGN VARS1 HSPA9 MED20 HSPE1 TBX3 LIMA1 LAD1 FBXO11 CCNT1 CNDP2 FLOT1 PPP6R2 CUX1 YTHDF3	9.56e-07	1247	200	23	27684187
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	AGO2 HK2 MYO1C MYCBP2 LRSAM1 ACTL6A MCCC1 GTF3C5 MDN1 PLAA NCAPD2 VARS1 HSPA9 PNP GNE UBR4 DOCK10 SMTN ARG1 CCNT1 DYNC1LI1 PDCD11 MACF1 AHNAK2	1.08e-06	1353	200	24	29467282
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GPRASP1 DCHS2 ERG MYCBP2 LRSAM1 EYA3 METAP1 PTPRA GLUL VARS1 HSPA9 GPRASP2 UBR4 FBXO11 SMG5 VPS9D1 MAST1 MACF1 ATP1A2 FLOT1 PCCB SNX1 CUX1	1.59e-06	1285	200	23	35914814
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	MYO1C PABPC4 ACTL6A IVD YTHDF1 MDN1 LPCAT2 NCAPD2 ALDOC HSPA9 LIMA1 IDH3A KIAA1217 AP3B2 DYNC1LI1 MACF1 FLOT1 YTHDF3	2.25e-06	847	200	18	35235311
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	PABPC4 RYR2 IVD YTHDF1 IDH3A VIRMA CCNT1 MACF1 YTHDF3	2.32e-06	197	200	9	20811636
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	HK2 MYO1A ACTL6A FOXA2 GTF3C5 TBC1D32 MDN1 NCAPD2 TOP3B VARS1 NRF1 FOS UBR4 FBXO11 SMG5 ASH2L KANSL3 CUX1	2.65e-06	857	200	18	25609649
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	VPS13C CGN KIF17 UBR4 ZFP28 VIRMA KANSL3 SH3PXD2B	3.15e-06	153	200	8	10718198
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYCBP2 CDK12 PABPC4 SPART ACTL6A GTF3C5 MDN1 NCAPD2 GLUL ALDOC VARS1 HSPA9 PNP HSPE1 LIMA1 UBR4 IDH3A ASH2L CHMP2B DYNC1LI1 MACF1	3.37e-06	1149	200	21	35446349
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	AGO2 MYO1C ACTL6A PTPRA VARS1 HSPA9 HSPG2 UBR4 NCKIPSD PCCB	3.64e-06	266	200	10	19380743
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	CDK12 SPART EYA3 GTF3C5 METAP1 PLAA VARS1 HSPA9 PNP HSPG2 IDH3A IGF2R H1-6 CNDP2 DYNC1LI1 ATP1A2 FLOT1 HTT	3.70e-06	878	200	18	37223481
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ZHX3 CDK12 PABPC4 EYA3 PNP SMTN KANSL3 SH3PXD2B IGF2R DYNC1LI1 MACF1 CUX1 YTHDF3	3.99e-06	472	200	13	38943005
Pubmed	Tagging genes with cassette-exchange sites.	AGO2 HDAC4 CDK12 EYA3 DYSF PLAA LIMA1 UBR4 SMG5 ASH2L MACF1	4.33e-06	335	200	11	15741177
Pubmed	Developmental waves of mechanosensitivity acquisition in sensory neuron subtypes during embryonic development.	TRPM4 PKD1L1 TRPV6 NTRK1 TRPV5	5.41e-06	44	200	5	19322198
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAGI1 TES CANT1 CGN LIMA1 LAD1 CHMP2B SH3PXD2B SLC9A1 IGF2R KIAA1217 MACF1 FLOT1 SNX1	5.68e-06	565	200	14	25468996
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	TES ITGA3 FAT1 HSPA9 HSPG2 LIMA1 DDR2 SLC9A1 IGF2R FLOT1	6.67e-06	285	200	10	21423176
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ZHX3 MYCBP2 CDK12 CLCN6 PHLPP1 PRUNE2 DOCK10 SMG5 MACF1	6.83e-06	225	200	9	12168954
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	GON4L MDN1 KIAA1549L VARS1 HSPA9 LIMA1 VIRMA ZNF335 MACF1	9.36e-06	234	200	9	36243803
Pubmed	Functional proteomics mapping of a human signaling pathway.	MYCBP2 CDK12 PABPC4 SPART RYR2 METAP1 ZFYVE9 MAST4 GLUL HSPG2 UBR4 ASH2L PAXIP1 MACF1	9.43e-06	591	200	14	15231748
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYO1A MYO1C PABPC4 NMRAL1 SLC30A2 RYR2 IVD MDN1 GSPT2 NIP7 NCAPD2 TOP3B VARS1 HSPA9 HSPE1 LIMA1 UBR4 H1-6 MTTP MACF1 ATP1A2 CUX1 CFAP46	1.05e-05	1442	200	23	35575683
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 HDAC4 MYCBP2 MCCC1 DYRK4 MDN1 MAST4 TESK2 CGN LIMA1 NCKIPSD BRSK2 VIRMA SH3PXD2B KIAA1217 MACF1 AHNAK2	1.13e-05	861	200	17	36931259
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	TES HK2 LRSAM1 PABPC4 GSPT2 PLAA NCAPD2 GLUL ALDOC VARS1 HSPA9 PNP PRUNE2 HSPE1 GNE UBR4 SCLY CNDP2 DYNC1LI1 MACF1 SNX1 HTT AHNAK2	1.21e-05	1455	200	23	22863883
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AGO2 EARS2 CDK12 VPS13C SPART METAP1 MAST4 NCAPD2 PITPNM2 SMG5 KANSL3 PDCD11 ATP1A2	1.35e-05	529	200	13	14621295
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MYO1C SPART ACTL6A MCCC1 IVD METAP1 PLAA NCAPD2 VARS1 HSPA9 HSPE1 LIMA1 UBR4 IDH3A CHMP2B ARG1 SH3PXD2B IGF2R JCHAIN PDCD11 SNX1 AHNAK2	1.44e-05	1367	200	22	32687490
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	HK2 MYO1C VARS1 HSPA9 HSPE1 LIMA1 IDH3A ARG1 IGF2R AHNAK2	1.46e-05	312	200	10	37120454
Pubmed	A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export.	TES AGO2 HK2 ATP7B MYO1C PLAA CLCN7 PNP LIMA1 IGF2R FLOT1	1.88e-05	392	200	11	33144569
Pubmed	A 1.1-Mb segmental deletion on the X chromosome causes meiotic failure in male mice.	GPRASP1 ARMCX2 GPRASP2 H1-6	1.95e-05	28	200	4	23677977
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ZHX3 GON4L CEP76 COL6A1 NCKIPSD NLRP1 CHMP2B PAXIP1 NUTM2F SNX1 CUX1	2.16e-05	398	200	11	35016035
Pubmed	Maternal bile acid transporter deficiency promotes neonatal demise.	ABCA3 HK2 FOXA2 PTGS2 FOS	2.33e-05	59	200	5	26416771
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	MCCC1 RYR2 IVD CKMT2 PNPT1 HSPA9 HSPE1 COL6A1 IDH3A PCCB	2.43e-05	331	200	10	29199018
Pubmed	Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.	MYO1C MYCBP2 VPS13C CGN GLUL HSPA9 KIAA1217 CNDP2 FLOT1	2.43e-05	264	200	9	32814769
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	TES MYO1A MYO1C PABPC4 NMRAL1 ITGA3 MDN1 NCAPD2 HSPA9 HSPE1 LIMA1 UBR4 IDH3A YTHDF3	2.56e-05	647	200	14	26618866
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	MYO1C VPS13C ITGA3 DYSF FAT1 GLUL GATD1 ALDOC PNP HSPG2 COL6A1 NRF1 CHMP2B SLC5A2 IGF2R GHITM CNDP2 FLOT1	2.63e-05	1016	200	18	19056867
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYO1C MYCBP2 PABPC4 PNPT1 MDN1 CGN NCAPD2 HSPA9 PNP UBR4 VIRMA IGF2R PDCD11 MACF1	2.84e-05	653	200	14	22586326
Pubmed	Deletion of YTHDF1 (not YTHDF3) reduced brain and gut damage after traumatic brain injury.	YTHDF1 YTHDF3	3.29e-05	2	200	2	39081030
Pubmed	Alteration of calcium homeostasis in primary preeclamptic syncytiotrophoblasts: effect on calcium exchange in placenta.	TRPV6 TRPV5	3.29e-05	2	200	2	20178461
Pubmed	The TRPV5/6 calcium channels contain multiple calmodulin binding sites with differential binding properties.	TRPV6 TRPV5	3.29e-05	2	200	2	22354706
Pubmed	Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane.	TRPV6 TRPV5	3.29e-05	2	200	2	16564089
Pubmed	Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells.	TRPV6 TRPV5	3.29e-05	2	200	2	19295174
Pubmed	Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity.	TRPV6 TRPV5	3.29e-05	2	200	2	23968883
Pubmed	Expression of calcium channels along the differentiation of cultured trophoblast cells from human term placenta.	TRPV6 TRPV5	3.29e-05	2	200	2	12390878
Pubmed	Complete genomic structure of the CLCN6 and CLCN7 putative chloride channel genes(1).	CLCN6 CLCN7	3.29e-05	2	200	2	10500249
Pubmed	AP-1γ2 is an adaptor protein 1 variant required for endosome-to-Golgi trafficking of the mannose-6-P receptor (CI-MPR) and ATP7B copper transporter.	ATP7B IGF2R	3.29e-05	2	200	2	38307383
Pubmed	TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice.	TRPV6 TRPV5	3.29e-05	2	200	2	30916584
Pubmed	Modulation of neuritogenesis by a protein implicated in X-linked mental retardation.	VCX3B VCX3A	3.29e-05	2	200	2	19812318
Pubmed	KIAA1429 Promotes Nasopharyngeal Carcinoma Progression by Mediating m6A Modification of PTGS2.	PTGS2 VIRMA	3.29e-05	2	200	2	37830191
Pubmed	Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies.	AGO2 HTT	3.29e-05	2	200	2	18669659
Pubmed	Interaction of the epithelial Ca2+ channels TRPV5 and TRPV6 with the intestine- and kidney-enriched PDZ protein NHERF4.	TRPV6 TRPV5	3.29e-05	2	200	2	16565876
Pubmed	Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6.	TRPV6 TRPV5	3.29e-05	2	200	2	16705151
Pubmed	m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance.	VIRMA YTHDF3	3.29e-05	2	200	2	30866959
Pubmed	PNPase knockout results in mtDNA loss and an altered metabolic gene expression program.	PNPT1 PNP	3.29e-05	2	200	2	30024931
Pubmed	Expression of transient receptor potential vanilloid channels TRPV5 and TRPV6 in retinal pigment epithelium.	TRPV6 TRPV5	3.29e-05	2	200	2	20405023
Pubmed	A single amino acid mutation results in a rapid inactivation of epithelial calcium channels.	TRPV6 TRPV5	3.29e-05	2	200	2	11846401
Pubmed	Pericellular colocalisation and interactive properties of type VI collagen and perlecan in the intervertebral disc.	HSPG2 COL6A1	3.29e-05	2	200	2	27377666
Pubmed	Expression and prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer after curative resection.	TRPV6 TRPV5	3.29e-05	2	200	2	24761864
Pubmed	Fast and slow inactivation kinetics of the Ca2+ channels ECaC1 and ECaC2 (TRPV5 and TRPV6). Role of the intracellular loop located between transmembrane segments 2 and 3.	TRPV6 TRPV5	3.29e-05	2	200	2	12077127
Pubmed	Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.	PTGS2 ARG1	3.29e-05	2	200	2	16186186
Pubmed	N6-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner.	HK2 VIRMA	3.29e-05	2	200	2	35546050
Pubmed	[The functional characteristics oF TRPV5 and TRPV6 channels in normal and transformed human blood lymphocytes].	TRPV6 TRPV5	3.29e-05	2	200	2	24592736
Pubmed	Tat-heat shock protein 10 ameliorates age-related phenotypes by facilitating neuronal plasticity and reducing age-related genes in the hippocampus.	TAT HSPE1	3.29e-05	2	200	2	38011257
Pubmed	[The nucleotide sequence features of the mature microRNA seem to be responsible for the affinity to human Ago2 AND Ago3 proteins].	AGO2 AGO3	3.29e-05	2	200	2	21634124
Pubmed	HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.	HDAC4 HTT	3.29e-05	2	200	2	24302884
Pubmed	Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.	RYR2 HTT	3.29e-05	2	200	2	32897880
Pubmed	ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family.	CLCN6 CLCN7	3.29e-05	2	200	2	8543009
Pubmed	Cytoplasmic m6A reader YTHDF3 promotes mRNA translation.	YTHDF1 YTHDF3	3.29e-05	2	200	2	28106076
Pubmed	Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6.	TRPV6 TRPV5	3.29e-05	2	200	2	12574114
Pubmed	Structural conservation of the genes encoding CaT1, CaT2, and related cation channels.	TRPV6 TRPV5	3.29e-05	2	200	2	11549322
Pubmed	[TRPV5 and TRPV6 calcium channels in human T cells].	TRPV6 TRPV5	3.29e-05	2	200	2	19140341
Pubmed	In silico discovery and experimental validation of new protein-protein interactions.	DYSF HTT	3.29e-05	2	200	2	21280221
Pubmed	A role for huntington disease protein in dendritic RNA granules.	AGO2 HTT	3.29e-05	2	200	2	20185826
Pubmed	Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer.	ITGA3 PTGS2	3.29e-05	2	200	2	24950714
Pubmed	NF-κB dependent up-regulation of TRPC6 by Aβ in BV-2 microglia cells increases COX-2 expression and contributes to hippocampus neuron damage.	PTGS2 TRPV6	3.29e-05	2	200	2	28458019
Pubmed	Huntingtin interacts with the receptor sorting family protein GASP2.	GPRASP2 HTT	3.29e-05	2	200	2	16835690
Pubmed	DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression.	DDR2 ARG1	3.29e-05	2	200	2	37996700
Pubmed	The exon-intron architecture of human chloride channel genes is not conserved.	CLCN6 CLCN7	3.29e-05	2	200	2	9565675
Pubmed	Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species.	SLC5A2 SLC9A1	3.29e-05	2	200	2	34205045
Pubmed	First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation.	TRPV6 TRPV5	3.29e-05	2	200	2	25164318
Pubmed	Myosin-1a is critical for normal brush border structure and composition.	MYO1A MYO1C	3.29e-05	2	200	2	15758024
Pubmed	Human Argonaute2 and Argonaute3 are catalytically activated by different lengths of guide RNA.	AGO2 AGO3	3.29e-05	2	200	2	33122430
Pubmed	Cyclin-dependent kinase 12 increases 3' end processing of growth factor-induced c-FOS transcripts.	CDK12 FOS	3.29e-05	2	200	2	25384976
Pubmed	Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the Ca(2+)-sensor calmodulin.	TRPV6 TRPV5	3.29e-05	2	200	2	15123711
Pubmed	Single-channel activities of the human epithelial Ca2+ transport proteins CaT1 and CaT2.	TRPV6 TRPV5	3.29e-05	2	200	2	11719848
Pubmed	Concerted action of associated proteins in the regulation of TRPV5 and TRPV6.	TRPV6 TRPV5	3.29e-05	2	200	2	17233615
Pubmed	YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation.	AGO2 YTHDF1	3.29e-05	2	200	2	34821414
Pubmed	Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts.	AGO2 HTT	3.29e-05	2	200	2	32696070
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	TRPM4 MYCBP2 VARS1 GNE UBR4 MOXD1 PPP6R2 SNX1	3.38e-05	212	200	8	33853758
Pubmed	A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.	TRPM4 PKD1L1 TRPV6 TRPV5	3.81e-05	33	200	4	19834762
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TES AGO2 VPS13C PKD1L1 MCCC1 MAST4 AGO3 CGN HSPA9 SH3PXD2B IGF2R KIAA1217 DYNC1LI1 FLOT1 PPP6R2 PCCB	3.82e-05	853	200	16	28718761
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	MAGI1 AGO2 MYO1C VPS13C MCCC1 NCAN AP3B2 MAST1 DYNC1LI1 MACF1 FLOT1	4.37e-05	430	200	11	32581705
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	HK2 MYO1C MYCBP2 EARS2 VPS13C ARMCX2 IVD PNPT1 MDN1 NIP7 TOP3B HSPA9 HSPE1 UBR4 IDH3A CHMP2B KIAA1217 GHITM PDCD11 FLOT1 CUX1 AHNAK2	5.57e-05	1496	200	22	32877691
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	TES MYO1C MCCC1 GLUL KIAA1217 AHNAK2	6.48e-05	118	200	6	30979931
Interaction	TOP3B interactions	TRPM4 AGO2 HDAC4 MYO1C MYCBP2 CDK12 ITGA3 DYSF RNF43 YTHDF1 FAT1 MDN1 CLCN7 CANT1 NCAPD2 NLRC5 TOP3B LRRC8E PITPNM2 HSPG2 LIMA1 NRF1 UBR4 LAD1 KTI12 SMG5 KANSL3 GAS2L1 SH3PXD2B IGF2R ZNF335 PAXIP1 PDCD11 YTHDF3 HTT AHNAK2	2.05e-07	1470	195	36	int:TOP3B
Interaction	ACTN4 interactions	MAGI1 TES AGO2 HDAC4 MYO1C INSIG1 PABPC4 NMRAL1 ALDOC TOP3B LIMA1 NTRK1 IDH3A VIRMA MICALL2 DYNC1LI1	1.88e-06	400	195	16	int:ACTN4
Interaction	KIF1C interactions	MAGI1 HDAC4 MYO1A GSPT2 TESK2 CGN LIMA1 VIRMA YTHDF3	2.56e-06	120	195	9	int:KIF1C
Interaction	MOV10 interactions	MAGI1 TES AGO2 CDK12 PABPC4 ACTL6A RNF43 YTHDF1 GSPT2 AGO3 CLCN6 CANT1 ALDOC TOP3B HSPA9 PNP LRRC8E LIMA1 NTRK1 UBR4 SMG5 VIRMA SMTN PNMA8A H1-6 CNDP2 MAST1 MACF1 PCCB SNX1 YTHDF3	2.72e-06	1297	195	31	int:MOV10
Interaction	CPEB4 interactions	AGO2 PABPC4 RNF43 YTHDF1 AGO3 TOP3B HSPA9 SMG5 VIRMA YTHDF3	2.95e-06	156	195	10	int:CPEB4
Interaction	SVIL interactions	TES MYO1C MYCBP2 RNF43 TBC1D32 TOP3B TBX3 LIMA1 FOS VIRMA PAXIP1 FLOT1	2.99e-06	233	195	12	int:SVIL
Interaction	OGA interactions	TES PSEN2 TOP3B NTRK1 KANSL3 PAXIP1 MAST1 DYNC1LI1 SNX1	4.66e-06	129	195	9	int:OGA
Interaction	NCOA6 interactions	AGO2 ERG TOP3B FOS VIRMA ASH2L ZNF335 PAXIP1 HTT	1.21e-05	145	195	9	int:NCOA6
Interaction	ANKRD17 interactions	AGO2 YTHDF1 AGO3 PHLPP1 TOP3B FOS NTRK1 SMG5 VIRMA PNMA8A YTHDF3	1.32e-05	226	195	11	int:ANKRD17
Interaction	AGO2 interactions	AGO2 HDAC4 PABPC4 MCCC1 YTHDF1 AGO3 TOP3B GPRASP2 FOS NTRK1 UBR4 VIRMA CNDP2 YTHDF3 HTT CFAP46	1.52e-05	472	195	16	int:AGO2
Interaction	LIMA1 interactions	MAGI1 TES HDAC4 MYO1C MYCBP2 TESK2 CGN PHLPP1 TOP3B LIMA1 FOS NTRK1 VIRMA PAXIP1 FLOT1	1.97e-05	429	195	15	int:LIMA1
Interaction	PLEKHA7 interactions	MAGI1 HDAC4 RNF43 TESK2 CGN LIMA1 VIRMA FLOT1	2.09e-05	119	195	8	int:PLEKHA7
Interaction	DENND4A interactions	MAGI1 HDAC4 PTPRA TESK2 CGN LIMA1 VIRMA	2.70e-05	90	195	7	int:DENND4A
Interaction	EDC3 interactions	MAGI1 AGO2 HDAC4 PABPC4 TESK2 LIMA1 NTRK1 DYNC1LI1 YTHDF3	2.78e-05	161	195	9	int:EDC3
Interaction	TIAM1 interactions	MAGI1 HDAC4 TESK2 CGN LIMA1 VIRMA CCNT1 MAST1 ATP1A2 FLOT1	3.23e-05	205	195	10	int:TIAM1
Interaction	CNOT6L interactions	AGO2 LRSAM1 AGO3 TOP3B SMG5 VIRMA YTHDF3	3.35e-05	93	195	7	int:CNOT6L
Interaction	SH3PXD2A interactions	MAGI1 HDAC4 TESK2 CGN LIMA1 NTRK1 VIRMA SH3PXD2B	3.53e-05	128	195	8	int:SH3PXD2A
Interaction	DCP1A interactions	AGO2 HDAC4 PABPC4 AGO3 TBX3 NTRK1 SMG5 PAXIP1 YTHDF3	3.54e-05	166	195	9	int:DCP1A
Interaction	INPP5E interactions	MAGI1 HDAC4 TESK2 CGN TOP3B LIMA1	3.91e-05	65	195	6	int:INPP5E
Interaction	FNDC4 interactions	TRPM4 LIMA1 GALNT11 GHITM	4.47e-05	21	195	4	int:FNDC4
Interaction	ASAP1 interactions	PTPRA NTRK1 DDR2 BRSK2 VIRMA MACF1 HTT	4.69e-05	98	195	7	int:ASAP1
Interaction	LSM14A interactions	AGO2 HDAC4 MYCBP2 INSIG1 YTHDF1 AGO3 TOP3B NTRK1 SMG5 MICALL2 YTHDF3	4.81e-05	260	195	11	int:LSM14A
Interaction	STARD13 interactions	MAGI1 HDAC4 TESK2 CGN LIMA1 VIRMA	5.05e-05	68	195	6	int:STARD13
Interaction	GIGYF2 interactions	MAGI1 AGO2 HDAC4 CEP76 RNF43 TESK2 CGN PHLPP1 LIMA1 NTRK1 VIRMA	5.34e-05	263	195	11	int:GIGYF2
Interaction	ATXN2 interactions	AGO2 HDAC4 PABPC4 RNF43 YTHDF1 PTPRA GSPT2 AGO3 TOP3B NTRK1 VIRMA YTHDF3	5.51e-05	312	195	12	int:ATXN2
Interaction	CNOT7 interactions	AGO2 YTHDF1 AGO3 PHLPP1 TOP3B SMG5 YTHDF3 HTT	6.69e-05	140	195	8	int:CNOT7
Interaction	LPIN3 interactions	MAGI1 HDAC4 TESK2 CGN TOP3B LIMA1	7.55e-05	73	195	6	int:LPIN3
Interaction	ILVBL interactions	CEP76 TBC1D32 MDN1 TESK2 NTRK1 VIRMA GHITM FLOT1 PPP6R2	7.55e-05	183	195	9	int:ILVBL
Interaction	MARK2 interactions	GPRASP1 AGO2 HDAC4 PTPRA AGO3 PHLPP1 NTRK1 VIRMA FLOT1 PPP6R2 HTT	7.71e-05	274	195	11	int:MARK2
Interaction	MCF2L interactions	HDAC4 TOP3B HSPE1 VIRMA	7.76e-05	24	195	4	int:MCF2L
Interaction	PHLDB2 interactions	MAGI1 HDAC4 MYO1C TESK2 CGN LIMA1 VIRMA FLOT1	7.76e-05	143	195	8	int:PHLDB2
Interaction	SETD1B interactions	HDAC4 TOP3B VIRMA ASH2L KANSL3 PAXIP1	8.79e-05	75	195	6	int:SETD1B
Interaction	NUTM2G interactions	NUTM2G VIRMA	9.31e-05	2	195	2	int:NUTM2G
Interaction	DSCR9 interactions	MYCBP2 EYA3 VARS1 GPRASP2 FBXO11 VPS9D1 MACF1 PCCB	9.42e-05	147	195	8	int:DSCR9
Interaction	AR interactions	ZHX3 ERG HDAC4 MYO1C MYCBP2 VPS13C ACTL6A MDN1 PLAA CGN GLUL HSPA9 MED20 TBX3 VIRMA ASH2L KANSL3 CCNT1 KIAA1217 PAXIP1 CNDP2 FLOT1 CUX1	9.46e-05	992	195	23	int:AR
Interaction	SPTAN1 interactions	TES ERG HDAC4 MYO1C MYCBP2 CEP76 AGO3 PHLPP1 TOP3B MED20 LIMA1 NTRK1 VIRMA FLOT1 HTT	1.02e-04	496	195	15	int:SPTAN1
Interaction	NAV1 interactions	MAGI1 HDAC4 TBC1D32 TESK2 CGN TOP3B LIMA1 VIRMA	1.04e-04	149	195	8	int:NAV1
Interaction	SORBS2 interactions	MYO1C MYCBP2 FAT1 LIMA1 BRSK2 VIRMA FLOT1	1.04e-04	111	195	7	int:SORBS2
Interaction	NPHP4 interactions	MYO1C CDK12 VPS13C TOP3B HSPA9 LIMA1 SMTN ARG1 PITPNM1 TSSK4	1.05e-04	236	195	10	int:NPHP4
Interaction	AP3M1 interactions	HDAC4 MYO1C AGO3 NTRK1 VIRMA AP3B2 FLOT1 HTT	1.08e-04	150	195	8	int:AP3M1
Interaction	MYO1D interactions	MYO1A MYO1C TOP3B FOS VIRMA PNMA8A PAXIP1 FLOT1 PPP6R2	1.18e-04	194	195	9	int:MYO1D
Interaction	CTNNB1 interactions	MAGI1 TES HDAC4 PSEN2 MYO1C PABPC4 ACTL6A PTGS2 PTPRA ZFYVE9 HSPA9 HSPE1 TBX3 NTRK1 DDR2 LAD1 VIRMA ASH2L KIAA1217 MAST1 FLOT1 CUX1 HTT	1.22e-04	1009	195	23	int:CTNNB1
Interaction	NADK interactions	MAGI1 HDAC4 TESK2 CGN TOP3B LIMA1	1.26e-04	80	195	6	int:NADK
Interaction	USP10 interactions	HDAC4 MYCBP2 PABPC4 YTHDF1 PHLPP1 TOP3B HSPA9 TBX3 NTRK1 PPP6R2 YTHDF3	1.27e-04	290	195	11	int:USP10
Interaction	RPS6KA2 interactions	MAGI1 YTHDF1 FAT1 TOP3B FOS VIRMA MACF1 PPP6R2 HTT	1.28e-04	196	195	9	int:RPS6KA2
Interaction	CDC25C interactions	MAGI1 HDAC4 MYO1C TESK2 CGN VARS1 LIMA1 BRSK2	1.42e-04	156	195	8	int:CDC25C
Interaction	YTHDF3 interactions	AGO2 PABPC4 YTHDF1 TBC1D32 AGO3 TOP3B NTRK1 SMG5 VIRMA YTHDF3	1.48e-04	246	195	10	int:YTHDF3
Interaction	EPRS1 interactions	TES AGO2 HDAC4 PABPC4 IVD DUS2 PHLPP1 TOP3B HSPA9 NTRK1 IDH3A VIRMA H1-6 PDCD11 HTT	1.48e-04	513	195	15	int:EPRS1
Interaction	RAB4A interactions	ATP7B VPS13C ZFYVE9 CLCN7 CANT1 PNP IDH3A IGF2R KIAA1217 CNDP2 DYNC1LI1 SNX1 HTT AHNAK2	1.53e-04	457	195	14	int:RAB4A
Interaction	RASAL2 interactions	MAGI1 HDAC4 RNF43 TESK2 CGN LIMA1 VIRMA FLOT1	1.55e-04	158	195	8	int:RASAL2
Interaction	FAM120A interactions	AGO2 HDAC4 PABPC4 DYSF YTHDF1 GSPT2 TOP3B NTRK1 DDR2 VIRMA H1-6 YTHDF3	1.59e-04	349	195	12	int:FAM120A
Interaction	ANKRD34A interactions	MAGI1 HDAC4 TESK2 TOP3B LIMA1	1.59e-04	53	195	5	int:ANKRD34A
Interaction	UBAP2L interactions	AGO2 HDAC4 PABPC4 YTHDF1 AGO3 PHLPP1 TOP3B NTRK1 SMG5 VIRMA YTHDF3	1.62e-04	298	195	11	int:UBAP2L
Interaction	BICD1 interactions	TES AGO3 HSPA9 NTRK1 NCKIPSD VIRMA SH3PXD2B MICALL2 DYNC1LI1 PCCB	1.68e-04	250	195	10	int:BICD1
Interaction	PEX5L interactions	AGO2 AGO3 KIAA1217 NCAN HTT	1.73e-04	54	195	5	int:PEX5L
Interaction	CDH1 interactions	MAGI1 TES RNF43 CLCN7 CANT1 CGN PHLPP1 HSPA9 LIMA1 DDR2 LAD1 CHMP2B SH3PXD2B SLC9A1 IGF2R KIAA1217 MACF1 FLOT1 SNX1	1.75e-04	768	195	19	int:CDH1
Interaction	LARP1 interactions	MAGI1 AGO2 PABPC4 RNF43 GSPT2 TESK2 CGN PHLPP1 LIMA1 NTRK1 VIRMA PAXIP1 MAST1 DYNC1LI1	1.83e-04	465	195	14	int:LARP1
Interaction	PCNX2 interactions	SLC30A2 TOP3B VIRMA	1.84e-04	12	195	3	int:PCNX2
Interaction	CKMT2 interactions	INSIG1 CKMT2 ALDOC HSPE1 COL6A1 NRF1	1.88e-04	86	195	6	int:CKMT2
Interaction	HUWE1 interactions	TES ERG HDAC4 MYCBP2 ACTL6A MCCC1 EYA3 PLAA NCAPD2 GLUL TOP3B VARS1 HSPA9 MED20 NTRK1 IDH3A VIRMA KLHL11 IGF2R DYNC1LI1 MACF1 PCCB HTT AHNAK2	1.91e-04	1110	195	24	int:HUWE1
Interaction	SETBP1 interactions	VIRMA ASH2L H1-6 HTT	1.91e-04	30	195	4	int:SETBP1
Interaction	SF1 interactions	TES HDAC4 ACTL6A YTHDF1 PLAA PHLPP1 ALDOC VARS1 NTRK1 IDH3A YTHDF3	1.92e-04	304	195	11	int:SF1
Interaction	PPM1H interactions	MAGI1 HDAC4 TESK2 CGN LIMA1 VIRMA IGF2R	1.97e-04	123	195	7	int:PPM1H
Interaction	PAXIP1 interactions	ERG CDK12 GTF3C5 NCAPD2 TOP3B LIMA1 FOS VIRMA ASH2L PAXIP1 MAST1 PDCD11	2.06e-04	359	195	12	int:PAXIP1
Interaction	SH3RF3 interactions	MAGI1 HDAC4 TESK2 CGN LIMA1	2.06e-04	56	195	5	int:SH3RF3
Interaction	LARP4 interactions	AGO2 MYO1C RNF43 YTHDF1 GSPT2 TOP3B NTRK1 MAST1 YTHDF3	2.14e-04	210	195	9	int:LARP4
Interaction	PPP6R3 interactions	TES RNF43 NCAPD2 VARS1 NTRK1 BRSK2 VIRMA ASH2L PAXIP1 PPP6R2	2.17e-04	258	195	10	int:PPP6R3
Interaction	DCLK1 interactions	MAGI1 HDAC4 MYCBP2 TESK2 CGN LIMA1 HTT	2.39e-04	127	195	7	int:DCLK1
Interaction	CAMSAP2 interactions	MAGI1 HDAC4 TESK2 CGN LIMA1 NTRK1 VIRMA MACF1	2.46e-04	169	195	8	int:CAMSAP2
Interaction	WWTR1 interactions	AGO2 MYCBP2 CDK12 ACTL6A CGN NCAPD2 LIMA1 ASH2L SH3PXD2B PDCD11 SNX1 CUX1 HTT	2.49e-04	422	195	13	int:WWTR1
Interaction	SOX2 interactions	AGO2 ERG MYO1C CDK12 PABPC4 ACTL6A GTF3C5 YTHDF1 MDN1 NIP7 NCAPD2 HSPA9 PNP HSPE1 COL6A1 TBX3 LIMA1 UBR4 BCDIN3D ASH2L CCNT1 KIAA1217 JCHAIN PAXIP1 PDCD11 MACF1 FLOT1 CUX1	2.59e-04	1422	195	28	int:SOX2
Interaction	GNL1 interactions	HDAC4 PABPC4 ALDOC NTRK1 UBR4 HTT	2.72e-04	92	195	6	int:GNL1
Interaction	GAB2 interactions	MAGI1 HDAC4 TESK2 CGN LIMA1 NTRK1 VIRMA	2.76e-04	130	195	7	int:GAB2
Interaction	SRSF12 interactions	MAGI1 HDAC4 GSPT2 TESK2 CGN LIMA1 H1-6	2.76e-04	130	195	7	int:SRSF12
Interaction	EMID1 interactions	YTHDF1 TOP3B UBR4 PPP6R2	2.79e-04	33	195	4	int:EMID1
Interaction	ZC3HAV1 interactions	TES AGO2 INSIG1 PABPC4 RNF43 YTHDF1 AGO3 NIP7 PHLPP1 TOP3B NTRK1 VIRMA CCNT1 H1-6 PDCD11 YTHDF3	2.83e-04	606	195	16	int:ZC3HAV1
Interaction	PITPNM2 interactions	HDAC4 TOP3B PITPNM2	3.00e-04	14	195	3	int:PITPNM2
Interaction	WDR1 interactions	MYO1C MYCBP2 PABPC4 TOP3B HSPE1 LIMA1 FOS NTRK1 SCLY	3.02e-04	220	195	9	int:WDR1
Interaction	KSR1 interactions	MAGI1 HDAC4 CDK12 TESK2 CGN LIMA1 VIRMA	3.03e-04	132	195	7	int:KSR1
Interaction	AFAP1 interactions	TES MYO1C LIMA1 VIRMA H1-6	3.09e-04	61	195	5	int:AFAP1
Interaction	AP3D1 interactions	HDAC4 RNF43 AGO3 PHLPP1 TOP3B NTRK1 VIRMA AP3B2	3.24e-04	176	195	8	int:AP3D1
Interaction	CDC25B interactions	MAGI1 HDAC4 TESK2 CGN LIMA1 DDR2 BRSK2	3.32e-04	134	195	7	int:CDC25B
Interaction	KMT2C interactions	ERG TOP3B FOS VIRMA ASH2L KANSL3 PAXIP1	3.32e-04	134	195	7	int:KMT2C
Interaction	PTPN14 interactions	MAGI1 HDAC4 RNF43 TESK2 CGN LIMA1 VIRMA FLOT1	3.36e-04	177	195	8	int:PTPN14
Interaction	GIGYF1 interactions	MAGI1 AGO2 HDAC4 RNF43 TESK2 CGN LIMA1 YTHDF3	3.36e-04	177	195	8	int:GIGYF1
Interaction	KANSL1 interactions	HDAC4 DUS2 TOP3B VIRMA ASH2L KANSL3	3.42e-04	96	195	6	int:KANSL1
Interaction	CNOT2 interactions	AGO2 YTHDF1 AGO3 TOP3B SMG5 KANSL3 YTHDF3 HTT	3.49e-04	178	195	8	int:CNOT2
Interaction	ELAVL3 interactions	HDAC4 NTRK1 MAST1 HTT	3.52e-04	35	195	4	int:ELAVL3
Interaction	DCTN1 interactions	TES MYCBP2 MCCC1 YTHDF1 NCAPD2 TOP3B NTRK1 VIRMA SH3PXD2B KIAA1217 DYNC1LI1 MACF1 SNX1 HTT	3.59e-04	497	195	14	int:DCTN1
Interaction	PSAT1 interactions	PTPRA HSPA9 PNP HSPG2 NTRK1 VIRMA	3.62e-04	97	195	6	int:PSAT1
Interaction	GPR158 interactions	HDAC4 BRSK2 VIRMA	3.73e-04	15	195	3	int:GPR158
Interaction	TUBB4B interactions	TES MYCBP2 INSIG1 CEP76 RNF43 AGO3 PHLPP1 VARS1 NTRK1 UBR4 NLRP1 VIRMA CCNT1 MICALL2 DYNC1LI1	3.78e-04	560	195	15	int:TUBB4B
Interaction	MKRN2 interactions	AGO2 HDAC4 PABPC4 RNF43 TBC1D32 PTPRA AGO3 TOP3B TBX3 SMG5 MACF1 YTHDF3	3.88e-04	385	195	12	int:MKRN2
Interaction	ZFP36 interactions	AGO2 PTGS2 YTHDF1 AGO3 TOP3B SMG5 METTL9 YTHDF3	3.91e-04	181	195	8	int:ZFP36
Interaction	EPS15L1 interactions	PHLPP1 TOP3B NTRK1 NCKIPSD LRRC4C VIRMA HTT	3.97e-04	138	195	7	int:EPS15L1
Interaction	TNRC6C interactions	AGO2 PABPC4 AGO3 TOP3B KTI12 VIRMA YTHDF3	3.97e-04	138	195	7	int:TNRC6C
Interaction	DENND4C interactions	MAGI1 HDAC4 TESK2 CGN PHLPP1 LIMA1 VIRMA	4.33e-04	140	195	7	int:DENND4C
Interaction	DENND1A interactions	MAGI1 HDAC4 TESK2 CGN TOP3B LIMA1	4.49e-04	101	195	6	int:DENND1A
Interaction	CTTN interactions	TES MYO1C MYCBP2 YTHDF1 GSPT2 PHLPP1 HSPA9 NTRK1 NCKIPSD BRSK2 CCNT1 SNX1 YTHDF3	4.60e-04	450	195	13	int:CTTN
Interaction	CHCHD3 interactions	HDAC4 MYO1C ARMCX2 CKMT2 TOP3B GPRASP2 NTRK1 IDH3A VIRMA HTT	4.64e-04	284	195	10	int:CHCHD3
GeneFamily	Variable charge X/Y family	VCX3B VCX3A VCY	8.37e-06	6	137	3	368
GeneFamily	Phosphatidylinositol transfer proteins	PITPNM2 PITPNM1	8.38e-04	6	137	2	1151
GeneFamily	Solute carriers	SLC30A2 SLC26A3 SLC17A4 SLC7A14 SLC1A7 SLC35G4 SLC5A2 SLC9A1 SLC25A2 SLC28A1	8.65e-04	395	137	10	752
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR4 FBXO11	1.17e-03	7	137	2	785
GeneFamily	Transient receptor potential cation channels	TRPM4 TRPV6 TRPV5	1.21e-03	28	137	3	249
GeneFamily	Myosins, class I	MYO1A MYO1C	1.55e-03	8	137	2	1097
GeneFamily	Argonaute/PIWI family	AGO2 AGO3	1.55e-03	8	137	2	408
GeneFamily	Chloride voltage-gated channels	CLCN6 CLCN7	2.46e-03	10	137	2	302
GeneFamily	Kelch like\|BTB domain containing	KLHL6 KLHL11 KLHL12	3.94e-03	42	137	3	617
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	GPRASP1 ARMCX2 GPRASP2	4.21e-03	43	137	3	409
Coexpression	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	MYO1C MYCBP2 EARS2 MCCC1 CC2D2B MAST4 CLCN6 PHLPP1 NLRC5 PGPEP1L	3.12e-06	199	199	10	M9332
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYCBP2 RYR2 COL6A1 DDR2 MOXD1 MICALL2 DYNC1LI1 MACF1 PCOLCE	2.94e-07	200	198	9	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HK2 DUS2 GSPT2 NCAPD2 ALG8 KTI12 MICALL2 TSSK4	1.06e-06	172	198	8	ebeda7ef181cac0109be750a98e7589c615d2724
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 RTN2 GLUL OTOA HSPG2 COL6A1 DDR2 PCOLCE	1.16e-06	174	198	8	68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0
ToppCell	AT1_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	MAGI1 TES MYO1C ITGA3 PTGS2 CGN COL4A4 AHNAK2	1.32e-06	177	198	8	3128b8d04687acee1ac4190b2569d6328b98eaf3
ToppCell	droplet-Mammary_Gland-nan-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNP HSPG2 COL6A1 LIMA1 FOS DDR2 JCHAIN PCOLCE	2.33e-06	191	198	8	8022059e434fd411dc539819f969bd4f94861281
ToppCell	droplet-Marrow-BM-1m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NMRAL1 ACTL6A YTHDF1 NCAPD2 GLUL VARS1 IDH3A ASH2L	2.71e-06	195	198	8	637b06ef3967b03f7165d102d316e8b7161a817d
ToppCell	AT1-AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	MAGI1 MYO1C ITGA3 FOXA2 PTGS2 CGN COL4A4 HSPG2	3.04e-06	198	198	8	a5b3617ea2ed4bffba59edcf6284799c2b3bbb29
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PADI4 HK2 DYSF PTGS2 FOS ARG1 IGF2R METTL9	3.04e-06	198	198	8	e76061e66f6d60f5735962aa7777dda8958caed9
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DYSF RYR2 PRUNE2 PITPNM2 COL6A1 SMTN MOXD1 ATP1A2	3.04e-06	198	198	8	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DYSF RYR2 PRUNE2 PITPNM2 COL6A1 SMTN MOXD1 ATP1A2	3.04e-06	198	198	8	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	droplet-Fat-Mat-18m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A FOXA2 TAT SLC26A3 LAD1 SLC17A4 H1-6	6.43e-06	156	198	7	0d79b4172896574b00faf00e87254f68d76f5512
ToppCell	droplet-Fat-Mat-18m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A FOXA2 TAT SLC26A3 LAD1 SLC17A4 H1-6	6.43e-06	156	198	7	cfd7f56f3155db677684827607e9008e975dbe70
ToppCell	droplet-Fat-Mat-18m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1A FOXA2 TAT SLC26A3 LAD1 SLC17A4 H1-6	6.43e-06	156	198	7	f09150aacb6121f913648ed3918f9cd4f22c61f2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCHS2 RYR2 HSPG2 TBX3 DDR2 DOCK10 PCOLCE	1.13e-05	170	198	7	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GJB4 CEP76 GPANK1 HSPG2 ZFP28 ARG1 KLHL11	1.26e-05	173	198	7	8bffd512a4e561e23cc04478e2ca6fd5d3771fe4
ToppCell	facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GJB4 CEP76 GPANK1 HSPG2 ZFP28 ARG1 KLHL11	1.26e-05	173	198	7	3e3c61468e703330788a10d850ef41a85680f86d
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 LRSAM1 TESK2 PHLPP1 FOS SLC25A2 MAST1	1.36e-05	175	198	7	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ZHX3 AGO2 NRF1 LAD1 ZXDB TBC1D13 MICALL2	1.46e-05	177	198	7	eb0cfe8e9a91910f9979608ed47add48d98ce4dd
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	GPRASP1 PRUNE2 FOS NTRK1 RNF175 SLC7A14 AP3B2	1.58e-05	179	198	7	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	severe-CD8+_T_naive\|World / disease stage, cell group and cell class	PADI4 RNF43 CLCN6 NRF1 NCKIPSD SLC1A7 CCNT1	1.69e-05	181	198	7	69eeeb7f326e230b07495d557f708fbe3312ac0a
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTGS2 GSPT2 COL6A1 DDR2 SH3PXD2B ATP1A2 PCOLCE	1.75e-05	182	198	7	f4b74c2756989812abe4e7055ec8918f69d56025
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	ABCA3 EARS2 CANT1 HSPA9 LRRC8E KLHL12 HTT	2.09e-05	187	198	7	a716b64ca03d9b61da765bf87f065ac9393303f1
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RTN2 GPRASP2 COL4A4 HSPG2 COL6A1 DDR2 SLC1A7	2.09e-05	187	198	7	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PTGS2 GLUL COL6A1 DDR2 CNDP2 PCOLCE	2.24e-05	189	198	7	6e52cac679e0541ca5f2be316bdabdbc34da6e18
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DCHS2 ERG ITGA3 PHLPP1 PITPNM2 TBX3 KIAA1217	2.31e-05	190	198	7	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PADI4 DYSF PRUNE2 FOS MUC19 ARG1 IGF2R	2.39e-05	191	198	7	d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARMCX2 FAT1 COL4A4 COL6A1 DDR2 ATP1A2 PCOLCE	2.39e-05	191	198	7	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 MYCBP2 VPS13C PTGS2 COL6A1 LIMA1 PCOLCE	2.47e-05	192	198	7	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG INPP5A DYSF NLRC5 PITPNM2 TBX3 KIAA1217	2.47e-05	192	198	7	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	MAGI1 ITGA3 MAST4 CGN ERICH3 KIAA1217 CFAP46	2.47e-05	192	198	7	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNP HSPG2 COL6A1 FOS DDR2 ATP1A2 PCOLCE	2.56e-05	193	198	7	80380358f44c2f4781676ec0f1fa94d4c69080d6
ToppCell	ILEUM-inflamed-(8)_Smooth_muscle_cells\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FAT1 PRUNE2 COL6A1 TBX3 DDR2 SLC1A7 AHNAK2	2.56e-05	193	198	7	084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG INPP5A DYSF NLRC5 PITPNM2 TBX3 KIAA1217	2.56e-05	193	198	7	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PTGS2 PNP HSPG2 COL6A1 MOXD1 PCOLCE	2.56e-05	193	198	7	2d891c00b8f0aace17d4c300b63e2341dcffa199
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 ABCA3 ITGA3 MAST4 CGN COL4A4 KIAA1217	2.56e-05	193	198	7	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	3'_v3-Lung-Mast-Mast_cells\|Lung / Manually curated celltypes from each tissue	ERG SLC30A2 PTGS2 FAT1 HSPG2 NTRK1 AHNAK2	2.64e-05	194	198	7	7b7f1714c4a9d9519c4d0e460cb87f2eb82392dd
ToppCell	3'_v3-Lung-Mast\|Lung / Manually curated celltypes from each tissue	ERG SLC30A2 PTGS2 FAT1 HSPG2 NTRK1 AHNAK2	2.64e-05	194	198	7	5e6eb81ddc9d5e22c1297734689f476d5a05bff6
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PTGS2 PNP HSPG2 COL6A1 DDR2 PCOLCE	2.64e-05	194	198	7	ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 ERG DYSF MAST4 PITPNM2 KIAA1217 MACF1	2.64e-05	194	198	7	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Mesenchymal_cells-Stromal_fibro.\|World / Lineage and Cell class	HK2 HSPG2 COL6A1 FOS ARG1 ATP1A2 PCOLCE	2.73e-05	195	198	7	69723b06c2a5c2aaf4d10874b11bca7f06822bdc
ToppCell	COVID-19_Severe\|World / Disease condition and Cell class	PADI4 DYSF ARG1 IGF2R METTL9 JCHAIN FLOT1	2.73e-05	195	198	7	22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab
ToppCell	facs-Trachea\|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HK2 PTGS2 PNP HSPG2 COL6A1 DDR2 PCOLCE	2.82e-05	196	198	7	8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6
ToppCell	facs-Trachea\|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 PTGS2 PNP HSPG2 COL6A1 DDR2 PCOLCE	2.82e-05	196	198	7	34020d6553309daa269dff05de0a8567211ea4d2
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RYR2 IVD COL6A1 DDR2 MICALL2 MACF1 PCOLCE	2.91e-05	197	198	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TES MYO1C ITGA3 CGN COL4A4 HSPG2 CUX1	2.91e-05	197	198	7	bbb7c106d5b96b8e95aeb3e5c293e104fceea234
ToppCell	5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRPM4 HK2 FOXA2 RNF43 GLUL GNE LAD1	2.91e-05	197	198	7	19cf283537c853fa902852e7b8ac1139729a931a
ToppCell	5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRPM4 HK2 FOXA2 RNF43 GLUL GNE LAD1	2.91e-05	197	198	7	e14a0e8a893c72356afc5508e3531ae0b23bfe16
ToppCell	PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TES MYO1C ITGA3 CGN COL4A4 HSPG2 CUX1	2.91e-05	197	198	7	b0fb5774525ba05f60c635d42f14bb8d79bff17c
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO1A RYR2 PRUNE2 COL6A1 SMTN MOXD1 ATP1A2	2.91e-05	197	198	7	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RTN2 GLUL HSPE1 HSPG2 COL6A1 DDR2 ATP1A2	3.01e-05	198	198	7	5e70246a9ce199cb2fb5379912b8ab59456219e4
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYCBP2 RYR2 COL6A1 DDR2 MOXD1 MACF1 PCOLCE	3.11e-05	199	198	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MYCBP2 COL6A1 DDR2 MOXD1 MICALL2 DYNC1LI1 PCOLCE	3.11e-05	199	198	7	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PADI4 HK2 DYSF PTGS2 FOS ARG1 METTL9	3.11e-05	199	198	7	86f2857ce60fbe59375411373ff49c684fd66ad0
ToppCell	ILEUM-non-inflamed-(8)_Smooth_muscle_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FAT1 PRUNE2 COL6A1 DDR2 SLC1A7 SMTN PCOLCE	3.11e-05	199	198	7	3368c0a90a47c4dcdfe70be3192550df0744e508
ToppCell	COVID-19-COVID-19_Mild-Myeloid-Neutrophil\|COVID-19_Mild / Disease, condition lineage and cell class	PADI4 DYSF PTGS2 GLUL FOS ARG1 IGF2R	3.11e-05	199	198	7	9f6b6731186ef399f952a75879eba66fd8ed3494
ToppCell	Control_saline-Hematopoietic_Myeloid-Granulocytic_cells\|Control_saline / Treatment groups by lineage, cell group, cell type	PADI4 SIRPB2 PTGS2 LPCAT2 KLHL6 FOS NTRK1	3.11e-05	199	198	7	a4d6525e70de39802ff9fdef0d877c4463a6200d
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HK2 PTGS2 MAST4 LPCAT2 GLUL FOS NTRK1	3.11e-05	199	198	7	a24a319d3ba8f4759f742af27610b4d62e359a2d
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	MYCBP2 COL6A1 DDR2 MOXD1 MICALL2 DYNC1LI1 PCOLCE	3.11e-05	199	198	7	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	Control-Control-Myeloid-Neutrophil\|Control / Disease, condition lineage and cell class	PADI4 DYSF PTGS2 GLUL NLRP1 ARG1 IGF2R	3.21e-05	200	198	7	95c41f147a1594d49e73cb56d86d301c3115ce20
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial\|6m / Sample Type, Dataset, Time_group, and Cell type.	PABPC4 COL6A1 TBX3 LIMA1 FOS DDR2 PCOLCE	3.21e-05	200	198	7	2cc98abf11f5b58707de45a2282f03d47f00f035
ToppCell	390C-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TES MYO1C PTGS2 MAST4 LPCAT2 PNP HSPG2	3.21e-05	200	198	7	c32ad15dede3f879007c0b856f2fed1f5b058103
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	HK2 PTGS2 LPCAT2 GLUL HSPE1 FOS NTRK1	3.21e-05	200	198	7	a338b2b94901e4614ef78e82f580b67891f7c849
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	PABPC4 COL6A1 TBX3 LIMA1 FOS DDR2 PCOLCE	3.21e-05	200	198	7	0f7431f670f3a175377cefae3479403a881bb8fb
ToppCell	390C-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TES MYO1C PTGS2 MAST4 LPCAT2 PNP HSPG2	3.21e-05	200	198	7	8a2c6c53a39fab86750526083f7254b7413b29af
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	HK2 PTGS2 LPCAT2 GLUL HSPE1 FOS NTRK1	3.21e-05	200	198	7	21de2cf284c8d2aa464f3d403f0e292e1f654e0a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAGI1 ABCA3 ARMCX2 RTN2 CGN LAD1	4.03e-05	141	198	6	3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAGI1 ABCA3 ARMCX2 RTN2 CGN LAD1	4.03e-05	141	198	6	cabb5b8c0874813c713508af2ac620ab0d61ab6f
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FOXA2 HS3ST3B1 ANKK1 COL4A4 COL6A1 NTRK1	4.90e-05	146	198	6	669001b772b6d6109a09727619ed5829122b48db
ToppCell	LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCHS2 MDN1 NCAPD2 PRUNE2 ASH2L AHNAK2	6.59e-05	154	198	6	16fdafb5c64d2db321554f87129a962d113f1668
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 EARS2 NLRC5 TBX3 LAD1 ADAMTS14	6.83e-05	155	198	6	c58a5fb8d853f12204e961d633e83452eb12a659
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGI1 EARS2 NLRC5 TBX3 LAD1 ADAMTS14	6.83e-05	155	198	6	9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8
ToppCell	10x5'-Lung-Myeloid_Monocytic-Cycling_mono\|Lung / Manually curated celltypes from each tissue	PADI4 RNF43 NCAPD2 VIRMA SMTN MICALL2	7.07e-05	156	198	6	63b8cf14361b282872bc1c5b65d9fbc83e81a089
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	GPRASP1 KIF17 TBX3 NRF1 LRRC4C JCHAIN	7.33e-05	157	198	6	f6210be2362d833c6d869ff921188bfc85dda11d
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	GPRASP1 KIF17 TBX3 NRF1 LRRC4C JCHAIN	7.33e-05	157	198	6	43a6b423fd70479822a564ff4225a1e4951ae5ed
ToppCell	Control-Endothelial-Epi-like-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NMRAL1 RNF43 GLUL NCKIPSD SLC7A14	7.33e-05	157	198	6	2c369660c752c0fb3bd798a561d3359e2f9aa983
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PADI4 LRSAM1 RNF43 KIAA1549L LPCAT2 FLOT1	7.33e-05	157	198	6	8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PADI4 LRSAM1 RNF43 KIAA1549L LPCAT2 FLOT1	7.33e-05	157	198	6	ee1be3c756b72fceac6b4ccb416dd4bd031a2193
ToppCell	PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PADI4 LRSAM1 RNF43 KIAA1549L LPCAT2 FLOT1	7.33e-05	157	198	6	008f938a338f43c3251dcac574f1b4f689926c71
ToppCell	Control-Endothelial-Epi-like\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PADI4 NMRAL1 RNF43 GLUL NCKIPSD SLC7A14	7.33e-05	157	198	6	4d02c50d5d1b892ea241e98724386d8a5a156a46
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GON4L MCCC1 SLC30A2 PITPNM2 BRSK2 SLC1A7	7.86e-05	159	198	6	235ed12053b337aca5abc2ce8727332b4ae3f8ae
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TESK2 TBX3 LIMA1 DDR2 BRSK2 ATP1A2	8.71e-05	162	198	6	5d902bb31e691aea9749617cc88303c2448f24b8
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TESK2 TBX3 LIMA1 DDR2 BRSK2 ATP1A2	8.71e-05	162	198	6	c7114e24cb5525abb9780ca3d35dbcc4eabd4b64
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TESK2 TBX3 LIMA1 DDR2 BRSK2 ATP1A2	8.71e-05	162	198	6	f1851a173d3bcca2981d934161ec85d1cc0af5a2
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	MAGI1 ABCA3 FAT1 MAST4 PITPNM2 KIAA1217	9.01e-05	163	198	6	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG CC2D2B KIAA1549L NIP7 HSPE1 HSPG2	9.64e-05	165	198	6	a74751e0ec857aa974bec04ccc747c004a8f6e01
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 LRSAM1 CEP76 CLCN6 ALDOC NLRP1	9.96e-05	166	198	6	a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXA2 RNF43 CKMT2 CGN LRRC8E COL4A4	9.96e-05	166	198	6	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM4 SLC30A2 RNF43 TRPV6 OTOA SLC26A3	9.96e-05	166	198	6	c22b0f3bf990d94b615a3aacee5de548da2db628
ToppCell	facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 LRSAM1 CEP76 CLCN6 ALDOC NLRP1	9.96e-05	166	198	6	0f641302a6b71c4badaaf20f51162bfc2386b167
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXA2 RNF43 CKMT2 CGN LRRC8E COL4A4	9.96e-05	166	198	6	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	facs-Marrow-T_cells-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM4 SLC30A2 RNF43 TRPV6 OTOA SLC26A3	9.96e-05	166	198	6	0975fc165bcc7e85f053d9d0244fffe407c23571
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	GPRASP1 ZHX3 ABCA3 ERG HDAC4 NTRK1	1.06e-04	168	198	6	45ccc0cb42d21f4853190e8e9ed9a54aefefe738
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	PADI4 CLCN6 OTOA NCKIPSD SLC5A2 TBC1D13	1.06e-04	168	198	6	c51244b4bdbfd961e2725306aa9cb25dd66d58bd
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPD2 ALG8 HS3ST3B1 ALDOC KLHL6 PITPNM1	1.06e-04	168	198	6	52fd65024af8683db11d931f7563cbe8eb815d1c
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSPT2 LPCAT2 TESK2 HS3ST3B1 VPS9D1 SLC28A1	1.10e-04	169	198	6	15a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	INSIG1 TAT PITPNM2 ARG1 SLC28A1 PCCB	1.17e-04	171	198	6	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo\|GI_small-bowel / Manually curated celltypes from each tissue	ERG PTGS2 GLUL SLC26A3 MAST1 ADAMTS14	1.21e-04	172	198	6	3df11aefc09762fd1f94441324551178e030b249
ToppCell	COVID-19_Mild-PLT_2\|COVID-19_Mild / Disease Group and Platelet Clusters	GPRASP1 MCCC1 DYRK4 TBC1D32 MYBPHL JCHAIN	1.25e-04	173	198	6	d11705e56b6b21eec963ea224717f27680c781ed
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	RYR2 PRUNE2 COL6A1 TBX3 SMTN ATP1A2	1.25e-04	173	198	6	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RYR2 PRUNE2 COL6A1 SMTN PGPEP1L ATP1A2	1.25e-04	173	198	6	cb6389536195443633adb06e5f1b7483530773d1
Drug	glutamate	TRPM4 HK2 EARS2 ACTL6A MCCC1 PTGS2 RYR2 MDN1 CLCN6 CLCN7 CGN GLUL TRPV6 TAT NRF1 TAS1R3 FOS NLRP1 IDH3A SLC1A7 ARG1 SLC25A2 CNDP2 ATP1A2 PCCB TRPV5 HTT	8.17e-08	962	198	27	CID000000611
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A	GON4L RYR2 MDN1 MAST4 COL6A1 SCLY SLC1A7 PITPNM1 TBC1D13 MICALL2 HTT	1.18e-06	195	198	11	2125_DN
Drug	trichostatin A ; Up 200; 1uM; MCF7; HT_HG-U133A_EA	INSIG1 ARMCX2 RTN2 ALDOC COL6A1 LIMA1 FOS NLRP1 SLC9A1 AHNAK2	3.78e-06	178	198	10	873_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	INSIG1 CEP76 ARMCX2 RTN2 ALDOC LIMA1 GNE NLRP1 SNX1 AHNAK2	4.84e-06	183	198	10	6910_UP
Drug	SC 19220; Down 200; 10uM; PC3; HT_HG-U133A	ATP7B VPS13C GON4L GTF3C5 DUS2 PLAA HSPG2 NRF1 SMG5 MICALL2	7.40e-06	192	198	10	7065_DN
Drug	clozapine; Down 200; 10uM; MCF7; HT_HG-U133A	ZHX3 TRPM4 MAST4 CLCN7 TAT NCKIPSD PITPNM1 VPS9D1 SLC9A1 AHNAK2	9.28e-06	197	198	10	5589_DN
Drug	aspartate	PSEN2 MCCC1 CKMT2 MDN1 CLCN6 CLCN7 GLUL HSPA9 TAT HSPE1 IDH3A SLC1A7 ARG1 SLC25A2 TRPV5 CUX1	1.31e-05	518	198	16	CID000000424
Disease	hepatocellular carcinoma (is_marker_for)	HDAC4 CDK12 PTGS2 NLRC5 TBX3 DDR2 FBXO11 ARG1 IGF2R CUX1	3.04e-05	301	192	10	DOID:684 (is_marker_for)
Disease	Developmental delay (disorder)	SPART ACTL6A PNPT1 ZNF335	9.70e-05	37	192	4	C0424605
Disease	phospholipids:total lipids ratio	PABPC4 DUS2 NLRC5 IGF2R ZNF335 NCAN MACF1 PCCB	1.28e-04	227	192	8	EFO_0020946
Disease	Inherited neuropathies	ZFYVE27 SPART NTRK1 MTTP	1.32e-04	40	192	4	C0598589
Disease	age at menopause	TOP3B PNP PITPNM2 DOCK10 FBXO11 ASH2L VPS9D1 SH3PXD2B PCCB	1.73e-04	302	192	9	EFO_0004704
Disease	Disorder of organic acid metabolism	MCCC1 IVD PCCB	2.06e-04	18	192	3	cv:C1263739
Disease	omega-6 polyunsaturated fatty acid measurement	ZHX3 AGO2 IGF2R ZNF335 NCAN PPP6R2 PCCB	3.21e-04	197	192	7	EFO_0005680
Disease	stomach cancer (is_marker_for)	CDK12 RNF43 TBX3 DDR2 FBXO11 CUX1	3.45e-04	142	192	6	DOID:10534 (is_marker_for)
Disease	2'-O-methyluridine measurement	PTPRA SLC28A1	4.16e-04	5	192	2	EFO_0800636
Disease	Huntington's disease (is_implicated_in)	GLUL NRF1 HTT	4.36e-04	23	192	3	DOID:12858 (is_implicated_in)
Disease	Asphyxia Neonatorum	PSEN2 PTGS2	6.21e-04	6	192	2	C0004045
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	NLRC5 PITPNM2 IGF2R ZNF335 MACF1 PCCB HTT	6.55e-04	222	192	7	EFO_0008317, EFO_0020943
Disease	Schizophrenia	MAGI1 HDAC4 PSEN2 INPP5A PTGS2 PTPRA PLAA GLUL KIF17 TOP3B HSPA9 ANKK1 NTRK1 PITPNM1 NCAN	7.06e-04	883	192	15	C0036341
Disease	osteoarthritis (is_implicated_in)	PTGS2 DDR2 ADAMTS14	7.88e-04	28	192	3	DOID:8398 (is_implicated_in)
Disease	erythronate measurement	PTPRA DDR2	8.66e-04	7	192	2	EFO_0021025
Disease	Erythrokeratodermia variabilis	TRPM4 GJB4	8.66e-04	7	192	2	C0265961
Disease	blood phosphate measurement	ZHX3 DYRK4 KIF17 PITPNM2 HSPG2 CUX1	1.00e-03	174	192	6	EFO_0010972
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	PABPC4 DUS2 NLRC5 IGF2R MTTP MACF1 PCCB	1.11e-03	243	192	7	EFO_0004612, EFO_0020944
Disease	argininate measurement	ARG1 IGF2R	1.15e-03	8	192	2	EFO_0800055
Disease	Squamous cell carcinoma of lung	MAST4 ANKK1 DDR2	1.17e-03	32	192	3	C0149782
Disease	PR interval	MAGI1 MYCBP2 DYSF RYR2 FAT1 MYBPHL HSPG2 FBXO11 LRRC4C MACF1	1.58e-03	495	192	10	EFO_0004462
Disease	Disproportionate short stature	CANT1 HSPG2 DDR2 SH3PXD2B	1.62e-03	77	192	4	C0878659
Disease	Liver Cirrhosis, Experimental	TES MYO1C FOXA2 DYSF PTGS2 IVD FAT1 NLRC5 PRUNE2 COL6A1 FOS DOCK10 IGF2R	1.76e-03	774	192	13	C0023893
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	NLRC5 PITPNM2 IGF2R ZNF335 MACF1 PCCB HTT	1.78e-03	264	192	7	EFO_0008317, EFO_0020944
Disease	Global developmental delay	SPART ACTL6A PNPT1 BRSK2 ZNF335	1.82e-03	133	192	5	C0557874
Disease	fish oil supplement exposure measurement, triglyceride measurement	METAP1 NCAN	1.83e-03	10	192	2	EFO_0004530, EFO_0600007
Disease	amino acid metabolic disorder (is_implicated_in)	IVD PCCB	2.23e-03	11	192	2	DOID:9252 (is_implicated_in)
Disease	Dystonia	EARS2 PNPT1 CHMP2B ATP1A2	2.43e-03	86	192	4	C0013421
Disease	Intellectual Disability	HDAC4 GON4L ACTL6A PNPT1 TAT BRSK2 ZNF335 MACF1 HTT	2.75e-03	447	192	9	C3714756
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	ZHX3 IGF2R NCAN MTTP PPP6R2 PCCB	3.27e-03	220	192	6	EFO_0004529, EFO_0008317
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	IGF2R ZNF335 NCAN MTTP MACF1 PCCB	3.57e-03	224	192	6	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	METAP1 NLRC5 IGF2R NCAN PPP6R2 PCCB	3.57e-03	224	192	6	EFO_0004574, EFO_0008317
Disease	Adenocarcinoma of large intestine	CDK12 RNF43 NTRK1 CUX1	3.62e-03	96	192	4	C1319315
Disease	unipolar depression, mood disorder, response to antidepressant	ERG NRF1	3.64e-03	14	192	2	EFO_0003761, EFO_0004247, GO_0036276
Disease	Adenocarcinoma Of Esophagus	SPART PTGS2	3.64e-03	14	192	2	C0279628
Disease	white matter hyperintensity measurement	HK2 PLSCR5 GON4L CC2D2B PNPT1 PGPEP1L PDCD11	3.76e-03	302	192	7	EFO_0005665
Disease	metabolite measurement	MCCC1 IVD PNPT1 PNP DDR2 SLC17A4 ARG1 TBC1D13 IGF2R SLC28A1	3.83e-03	560	192	10	EFO_0004725
Disease	hearing impairment	MYO1A PNPT1 OTOA SH3PXD2B	3.90e-03	98	192	4	C1384666
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	ZHX3 IGF2R NCAN MTTP PPP6R2 PCCB	3.98e-03	229	192	6	EFO_0004639, EFO_0008317
Disease	Hepatic fibrosis	KIAA1549L KLHL6 ARG1	4.01e-03	49	192	3	HP_0001395
Disease	schizophrenia (biomarker_via_orthology)	PTGS2 ASH2L	4.18e-03	15	192	2	DOID:5419 (biomarker_via_orthology)
Disease	periprosthetic osteolysis, disease progression measurement	INPP5A TBX3	4.18e-03	15	192	2	EFO_0008336, EFO_0009761
Disease	Barrett Epithelium	PTGS2 SLC9A1	4.76e-03	16	192	2	C1258085
Disease	Barrett Esophagus	PTGS2 SLC9A1	4.76e-03	16	192	2	C0004763
Disease	revision of total joint arthroplasty, aseptic loosening	PHLPP1 SLC28A1	4.76e-03	16	192	2	EFO_0010725, EFO_0020974
Disease	glaucoma (implicated_via_orthology)	NTRK1 SH3PXD2B	5.37e-03	17	192	2	DOID:1686 (implicated_via_orthology)
Disease	diabetic neuropathy (biomarker_via_orthology)	PTGS2 NTRK1	5.37e-03	17	192	2	DOID:9743 (biomarker_via_orthology)
Disease	Dupuytren Contracture	DCHS2 ERG KLHL6 DDR2	5.50e-03	108	192	4	EFO_0004229
Disease	mean arterial pressure	ERG HDAC4 INPP5A PABPC4 CLCN6 DOCK10 SLC9A1 KIAA1217 SLC28A1	5.61e-03	499	192	9	EFO_0006340
Disease	mean corpuscular hemoglobin concentration	ZHX3 AGO2 ATP7B ERG CDK12 LRSAM1 PABPC4 GON4L RNF43 CLCN6 SMG5 KIAA1217 NCAN MAST1 MACF1	5.98e-03	1105	192	15	EFO_0004528
Disease	4-ethylphenylsulfate measurement	SIRPB2 NRF1	6.02e-03	18	192	2	EFO_0021148
Disease	triglyceride measurement, intermediate density lipoprotein measurement	IGF2R MTTP PPP6R2 PCCB	6.06e-03	111	192	4	EFO_0004530, EFO_0008595

Protein segments in the cluster

Peptide	Gene	Start	Entry
MQVSEGSPEEGSLAK	ERICH3	1006	Q5RHP9
KDMGLVTPEAASLGT	CDK12	51	Q9NYV4
SGSEMLPVVKGAFIS	TBC1D32	601	Q96NH3
PGKGILAADESVGSM	ALDOC	26	P09972
MDGTTAPVTKSGAAK	ASB4	1	Q9Y574
KVAMVGDGVNDSPAL	ATP7B	1261	P35670
MAVPTELDGGSVKET	BCDIN3D	1	Q7Z5W3
MSFLEGKEPSVATLG	ANKK1	741	Q8NFD2
SVAKGGKMVGSPDTV	ERG	86	P11308
GIVKSPLAGDFITMQ	ACTL6A	191	O96019
PGTGKTMIARAVANE	SPATA5	396	Q8NB90
SAAETVTKGGIMLPE	HSPE1	21	P61604
VKATGHSGDPVMLVT	CFAP46	771	Q8IYW2
DEGEMAIISQKGTPG	COL4A4	961	P53420
AGSKVLILDEPTSGM	ABCA3	681	Q99758
KMRIPVAGGDKAASS	CCNT1	461	O60563
ELMGVGTESKVSVGI	CEP76	231	Q8TAP6
DGKKPSIAAVVGSMD	AGO3	606	Q9H9G7
DKLVMPADGEVGSNV	CC2D2B	586	Q6DHV5
GIEISGKMAKAPSAA	CHMP2B	171	Q9UQN3
AGVGPKAESVVGAAM	ARMCX2	121	Q7L311
VVSGPAAASAGSMVV	ADAMTS14	56	Q8WXS8
GKKPSIAAVVGSMDA	AGO2	606	Q9UKV8
SGLDIMEVNPSLGKT	ARG1	271	P05089
ESLAPGESATAVMGI	AP3B2	926	Q13367
VANATGAEEGEMKPV	ASH2L	21	Q9UBL3
GKSGPVEDFVSLAMV	HSPG2	3971	P98160
ATVKSMVREPGEGLA	PCOLCE	341	Q15113
KDPTVVIGSGLTMEE	EYA3	331	Q99504
PSLSTMKAIVECAGG	PAXIP1	986	Q6ZW49
DPGVEVTLTMKVASG	PADI4	71	Q9UM07
GILSKMVQAEDTAPG	OTOA	506	Q7RTW8
VGDAESMAISEPIKG	PNMA8A	276	Q86V59
GTVKEDAPVGSLVMT	FAT1	1041	Q14517
PFGSITSAKVMLEDG	PABPC4	316	Q13310
ELEQSATVMKSGGLP	NTRK1	231	P04629
TSVSEKSLAPGMALG	LAD1	236	O00515
EIKSGTTAPLGFDEM	MDN1	5211	Q9NU22
TMGDVVEKSLEGPLA	KLHL6	11	Q8WZ60
VTAMASLSVGVKPAE	HDAC4	1056	P56524
TPLASGKEMAEGAAS	HS3ST3B1	96	Q9Y662
DVAAGMIKPGVTTEE	METAP1	151	P53582
PAALDGKMETGDVIV	MAGI1	506	Q96QZ7
KTMISLSIGDPTVFG	TAT	71	P17735
APIAKVGVLAASMEA	LIMA1	496	Q9UHB6
DGMSVSDLGPVVLSL	NMRAL1	186	Q9HBL8
MKAPAAEAVAEGASG	GPANK1	76	O95872
VLAGLMEAQKSAVPG	KTI12	281	Q96EK9
MSVASLDLTGGLPEV	FOS	216	P01100
VGGLSTVAMCAPSEK	GHITM	226	Q9H3K2
SQMSPGDLAKVGVSE	LRSAM1	601	Q6UWE0
GVEKVLGELSMSSGE	MYO1A	656	Q9UBC5
PAVTMDLLSGKDVAV	DDR2	541	Q16832
SEDVITGPTIKNMDG	NCR3LG1	191	Q68D85
KSMEVLSVTDGGSPV	BRSK2	381	Q8IWQ3
ILKSMEFAPSEGAGT	CUX1	371	Q13948
DPNMKAGATSEGVLA	DYNC1LI1	431	Q9Y6G9
EMEKGLGATTHPTAA	HK2	46	P52789
SVGGLPVLASMTKAA	CANT1	21	Q8WVQ1
KEGPMIHSGSVIAAG	CLCN7	246	P51798
ESLVMGPQGVLSESK	C9orf131	481	Q5VYM1
PIGGMAGVKRASEDS	MICALL2	111	Q8IY33
DMGTVVLGKLESGSI	GSPT2	441	Q8IYD1
GTMGAAKVTGEVLDI	FLOT1	386	O75955
PADLDVTVKAAMIGA	PLSCR5	241	A0PG75
MAGKAAAPGTAVLLV	INPP5A	1	Q14642
GESGMKTVEDVGSPL	ITGA3	781	P26006
KMLSASGDPISVVKG	MTTP	716	P55157
KSPGVAMTTGLLVEG	MUC19	2461	Q7Z5P9
SAEVTGKTGLSAGVM	MUC19	5446	Q7Z5P9
GSPDVLESGVCMKAV	PGPEP1L	91	A6NFU8
TVSGSGSGMLEILPK	NLRP1	1291	Q9C000
AVDPLGQKGSVAMAI	GALNT11	581	Q8NCW6
AAKVGEMINVSVSGP	INSIG1	31	O15503
PVGMAAAAAVATGKK	NRF1	76	Q16656
SDVTDSKAMGPLAVG	PMS2P11	11	Q13670
DLGAGDGEVTKIMSP	METTL9	151	Q9H1A3
ETMVEVGAPFSLKGL	PTGS2	506	P35354
VLPAASAAVVTTGKM	KIAA1549L	801	Q6ZVL6
DINSGIPGIDEVMKT	LRRC4C	511	Q9HCJ2
ERAAATIVAMAGTGP	LRRC8E	181	Q6NSJ5
SIMGSDPKVRAGAVD	PITPNM2	1121	Q9BZ72
ASRGITAFIVEKGMP	IVD	221	P26440
SKSDIGEVILVGGMT	HSPA9	376	P38646
ASLDTPEGAIMGDVK	NLRC5	186	Q86WI3
GGMARAVAKAALSPV	MAST1	1401	Q9Y2H9
LIMEITAPDSQGKTG	MACF1	4396	Q9UPN3
PQGVIGKITAIDMDS	DCHS2	1206	Q6V1P9
SMGFIVAVKGKIASP	LPCAT2	121	Q7L5N7
PTAEIAVMGAKGAVE	PCCB	456	P05166
LQVATPGGKAMEFVD	GATD1	41	Q8NB37
PKKSEAAVGAEVSMT	DYRK4	486	Q9NR20
DIGIAMGISGSDVSK	ATP1A2	726	P50993
FVEKEGPMIHSGSVV	CLCN6	196	P51797
ETLAAAVPKIMASFG	HTT	226	P42858
GIGPEISAAVMKIFD	IDH3A	41	P50213
VAGSMEPGFAKTVER	KLHL11	411	Q9NVR0
VTPMATKRSGAGVAL	KLHL12	456	Q53G59
PAASASAGVAAMEKL	H1-6	6	P22492
IEKVLMGNIASGAEP	DOCK10	511	Q96BY6
KSEPGTSDGMNVLGI	SLC1A7	211	O00341
VEGMSVPKDEAVGAL	GNE	611	Q9Y223
MPGGRDALKSSVDAV	COL6A1	106	P12109
ITMIGAAPGKVADKV	FBXO11	306	Q86XK2
MADPVAGIAGSAAKS	GAS2L1	1	Q99501
KGEMPVSAGLAVGST	GON4L	1941	Q3T8J9
EDGNSVLMKAGSAPV	GJB4	246	Q9NTQ9
TGALLLSVVGGKMSE	DDX12P	786	Q92771
LDKVVELMTGGAQTP	AREL1	636	O15033
SKSIMAAAGVPVVEG	MCCC1	166	Q96RQ3
APMTGTIEKVFVKAG	MCCC1	651	Q96RQ3
MEAATAPEVAAGSKL	MYBPHL	1	A2RUH7
DTSSAKAAGGMLELP	MAST4	2481	O15021
PITMTLGQASAGAKE	KANSL3	676	Q9P2N6
RSKVPGVVSGAMSGA	KIAA1210	271	Q9ULL0
GGETKMVETALTPDA	JCHAIN	141	P01591
QTGEPAEDTSGVIKM	DUS2	341	Q9NX74
MSTGPDVKATVGDIS	SLC17A4	1	Q9Y2C5
VMLPGVLAGVSAEES	SCNN1D	776	P51172
ASKGETGPMVAATLK	RYR2	3746	Q92736
SMSKISAPGGEIEEE	DYSF	481	O75923
KLGADAVGMSTVPEV	PNP	211	P00491
AEDVATGLLPGTVTM	PKD1L1	201	Q8TDX9
AAPAMVATLGTVTKD	PPP6R2	936	O75170
GIPSDGKGMISIIAA	PTPRA	701	P18433
PFIKTVGMVAGDEES	CKMT2	101	P17540
DFLVKVGTVTMGPSA	MED20	121	Q9H944
PATAGVKRESVGMEV	KIF17	711	Q9P2E2
SLAMGPVTNKTGLDA	FOXA2	421	Q9Y261
LAKGSSEETELPGMV	NUTM2F	626	A1L443
LAKGSSEETELPGMV	NUTM2G	611	Q5VZR2
MTGAEIESGAQVKPE	GPRASP1	1	Q5JY77
AGVKIAGTNAEVMPA	GLUL	186	P15104
SISNLGMAKTGPVVE	IGF2R	846	P11717
GMAKTGPVVEDSGSL	IGF2R	851	P11717
GVPSLSLGADMGSKV	RTN2	331	O75298
VDMDFGTGAVKITPA	VARS1	581	P26640
ATKMAAVTAPEAESG	VCX3A	56	Q9NNX9
GDRSTPAAVGAMEDK	TES	211	Q9UGI8
ATKMAAVTAPEAESG	VCX3B	56	Q9H321
ATKMAAVTAPEAESG	VCY	56	O14598
AKPIMDQLVGAAETG	TBX3	61	O15119
TGLQVSEKGASPDMA	PRUNE2	2201	Q8WUY3
AGEEDPSGMVTIITG	SMG5	961	Q9UPR3
MADIPLGFGVAAKST	NIP7	136	Q9Y221
TEVQVMGGARPKTEA	GPRASP2	76	Q96D09
LEQGDKVGVPAMSTL	NCAN	876	O14594
GVAEITPAEGKLMQS	RNF43	71	Q68DV7
VSGGKMLSALESTVP	KIAA1217	616	Q5T5P2
EMAQLAVGGPEKDTI	MYCBP2	3226	O75592
MVGLAVSGAVSKAVP	SLC26A3	136	P40879
LVGEPVLGAKMETAA	SKIV2L	1216	Q15477
MDSGVPISSAVAGVA	PNPT1	496	Q8TCS8
MKSGPGIQAAIDLTA	SLC25A2	1	Q9BXI2
VEGKDLSMALPSGQV	NCKIPSD	361	Q9NZQ3
ASVEGDPVIMKSDGF	EARS2	211	Q5JPH6
GASAPGKSMEASVDV	AHNAK2	686	Q8IVF2
GKSMEASVDVSAPKV	AHNAK2	691	Q8IVF2
PMSLLSVGKAGDASI	ALG8	391	Q9BVK2
AKVGDTVMVDGFTKP	ANKUB1	341	A6NFN9
PLVMVSSGSTKAVAG	CGN	346	Q9P2M7
MARGKPEIVGSNLDT	NCAPD2	781	Q15021
EATGKNVMLLPVGSA	CNDP2	426	Q96KP4
GLVAKEMAGPGVIVS	SLC7A14	76	Q8TBB6
SIMGSDPKVRAGAVD	PITPNM1	1036	O00562
APSDIMGAGVVLGSI	SLC35G4	306	P0C7Q5
TPMKSATEAELGGDA	TOP3B	391	O95985
AEALKPGMLLTGTVS	PDCD11	181	Q14690
TENTPMIAGLGKAAE	SCLY	296	Q96I15
EDVKTTGPAGAMNTL	SIRPB2	321	Q5JXA9
VSVGPLGSLDSLAMK	ZXDB	701	P98169
LEAVGTGIEPKAMSQ	ZFP28	86	Q8NHY6
MTGLKIGGDLTAAVT	YTHDF3	191	Q7Z739
GKSPLDGAMVVAASS	SPART	531	Q8N0X7
MGKGDVLEAAPTTTA	TSSK4	1	Q6SA08
VIGPHSSELAMVTGK	TAS1R3	141	Q7RTX0
PTGAMASADIVVGGV	MOXD1	66	Q6UVY6
TVGITDPEKIGDGMN	SNX1	146	Q13596
EAGSAPEMGAQKALI	SLC5A2	6	P31639
KSGGDQTSVDPMVLE	SH3PXD2B	141	A1X283
MAAGTAARKAAPVLE	RNF175	1	Q8N4F7
PEQGLMLTGSADKTV	PLAA	161	Q9Y263
LTPFKLAGVEGNTVM	TRPV6	281	Q9H1D0
PMATGANGLETKDET	nan	96	Q8N8P6
TVGMAKLDPSSQGAL	PSEN2	301	P49810
IELVESGGMGKIPSA	SLC9A1	586	P19634
PGIAKANMGVSREDV	TBC1D13	81	Q9NVG8
ITGSVGKGLAAITMD	VPS13C	3481	Q709C8
SISLTPVAKGLENMG	SLC28A1	11	O00337
VGGKDGLMDSTPALT	ZFYVE27	251	Q5T4F4
SVNMVIKDRPSDGLG	PHLPP1	1451	O60346
VAKMLPTLGGEEGVS	GTF3C5	36	Q9Y5Q8
MAAAAGDGTVKPLQS	VPS9D1	1	Q9Y2B5
DVSMGSEKLAVVGSP	TESK2	206	Q96S53
GASVDPAGVTMIDAV	UBR4	2406	Q5T4S7
VAMGKVSRTPVEAGV	ZNF335	401	Q9H4Z2
VGEALPKLSTGEMEV	ZHX3	211	Q9H4I2
GLTEVMEILKEGSSG	UHRF1BP1	786	Q6BDS2
SVVGLKQMLESSGDP	VIRMA	1476	Q69YN4
APMTEIKELAGSTGQ	ZNF468	111	Q5VIY5
LMEDIFGKETPSGVT	ZNF317	141	Q96PQ6
VAVGTAEPGGSMKTT	SMTN	446	P53814
ASTGGTKVVAMGVAP	TRPM4	176	Q8TD43
SKGVVSPIDGKSMET	ZFYVE9	1276	O95405
LTPFKLAGVEGNTVM	TRPV5	241	Q9NQA5
GMVGLKIGDVSSSAV	YTHDF1	186	Q9BYJ9
LVLMEGTPKGVDFTA	SLC30A2	226	Q9BRI3
VVMAAAAAGAAVGKP	ZNF784	181	Q8NCA9
VMISGESGAGKTEAT	MYO1C	136	O00159